BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND H3F3A, P84243, H3_3B, MGC87783, MGC87782, H3F3, H3_3A, ENSG00000163041, 3020 AND Diagnosis
48 results:

  • 1. Giant Cell Tumor of the Acromion: Case Report and Literature Review.
    Sano J; Chijiiwa Y; Nishio J
    In Vivo; 2024; 38(1):506-510. PubMed ID: 38148094
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Adult granulosa cell tumor of the testis with malignant tendency: A case report with genetic analysis using high-throughput sequencing.
    Deng L; Zeng J; Qiu JF; Yang LH; Ma J
    Medicine (Baltimore); 2023 Aug; 102(32):e34523. PubMed ID: 37565864
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. h3f3a mutation as a marker of malignant giant cell tumor of the bone: A case report and review of literature.
    Ratnagiri R; Uppin S
    J Cancer Res Ther; 2023; 19(3):832-834. PubMed ID: 37470622
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Multicentric Giant Cell Tumor of bone.
    Errani C; Tsukamoto S; Angulo Alvarado R; Righi A; Nitta Y; Donati DM; Mavrogenis AF
    Orthopedics; 2023; 46(6):e376-e380. PubMed ID: 37126833
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Giant cell tumour of bone in the rib cage treated with denosumab. A case report].
    Serret Miralles P; Orellana Fernández R; Parra Parente T; García-Chamón Brígido RB; Carrera Salas R
    Rev Esp Patol; 2023; 56(2):119-123. PubMed ID: 37061238
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Giant cell tumor of bone with h3f3B mutation: A case report.
    Wu R; Wu X; Weng X; Xiu Y; Xu G; Liu X; Liu X
    Medicine (Baltimore); 2023 Feb; 102(7):e32995. PubMed ID: 36800629
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Giant-cell-poor giant cell tumor of bone: report of two cases and literature review.
    Yakoub MA; Torrence D; Hwang S; Bartelstein M; Healey JH; Hameed M
    Skeletal Radiol; 2023 Sep; 52(9):1791-1798. PubMed ID: 36781420
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas.
    Fanburg-Smith JC; Smith JD; Flemming DJ
    Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognosis of patients with unresectable stage IV Colon cancer undergoing primary tumor resection: A multicenter study of minimally symptomatic or asymptomatic primary tumor.
    Ho MF; Lai VC; Ng DCK; Ng SSM
    Asian J Surg; 2023 Sep; 46(9):3710-3715. PubMed ID: 36522225
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Malignant Transformation of Giant Cell Tumour of bone: A Review of Literature and the Experience of a Referral Centre.
    Vari S; Riva F; Onesti CE; Cosimati A; Renna D; Biagini R; Baldi J; Zoccali C; Anelli V; Annovazzi A; Covello R; Ascione A; Casini B; Ferraresi V
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142631
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Anti-Histone H3.3 G34W antibody is a sensitive and highly specific immunohistochemistry marker for the diagnosis of Giant cell tumor of bone. A validation based on analysis of 198 cases from a single centre in India.
    Kamble A; Hui M; Rao KN; Narayanan R; Reddy BR; Uppin SG; Chandrasekhar P
    Indian J Pathol Microbiol; 2022; 65(3):617-629. PubMed ID: 35900490
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Chondroblastoma-like osteosarcoma: a clinicopathological and molecular study of a rare osteosarcoma variant.
    Gaeta R; Righi A; Gambarotti M; Aretini P; Lessi F; Mazzanti CM; Mancini I; Pinzani P; Belgio B; Sbaraglia M; Tos APD; Franchi A
    Histopathology; 2022 Sep; 81(3):389-401. PubMed ID: 35791778
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Giant-cell tumor of bone in 2022].
    Larousserie F; Audard V; Burns R; de Pinieux G
    Ann Pathol; 2022 Apr; 42(3):214-226. PubMed ID: 35523609
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation.
    Ishihara S; Yamamoto H; Iwasaki T; Toda Y; Yamamoto T; Yoshimoto M; Ito Y; Susuki Y; Kawaguchi K; Kinoshita I; Yamada Y; Kohashi K; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Kakuda Y; Nakashima Y; Oda Y
    Mod Pathol; 2022 May; 35(5):640-648. PubMed ID: 34785767
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Osteosarcoma: Old and New Challenges.
    Yoshida A
    Surg Pathol Clin; 2021 Dec; 14(4):567-583. PubMed ID: 34742481
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Reliability and Role of Mutation-specific h3f3a (Histone 3-3) G34W Immunohistochemistry to Differentiate Giant Cell Tumor of bone From its Clinicoradiologic and Histologic Mimics: An Institutional Study.
    Pasricha S; Pruthi M; Jajodia A; Kumar A; Gupta G; Sharma A; Tiwari A; Rohela H; Durga G; Kamboj M; Koyyala VPB; Mehta A
    Appl Immunohistochem Mol Morphol; 2022 Jan; 30(1):36-41. PubMed ID: 34347625
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Characteristics of patients ≥10 years of age with diffuse intrinsic pontine glioma: a report from the International DIPG/DMG Registry.
    Erker C; Lane A; Chaney B; Leary S; Minturn JE; Bartels U; Packer RJ; Dorris K; Gottardo NG; Warren KE; Broniscer A; Kieran MW; Zhu X; White P; Dexheimer PJ; Black K; Asher A; DeWire M; Hansford JR; Gururangan S; Nazarian J; Ziegler DS; Sandler E; Bartlett A; Goldman S; Shih CS; Hassall T; Dholaria H; Bandopadhayay P; Samson Y; Monje M; Fisher PG; Dodgshun A; Parkin S; Chintagumpala M; Tsui K; Gass D; Larouche V; Broxson E; Garcia Lombardi M; Wang SS; Ma J; Hawkins C; Hamideh D; Wagner L; Koschmann C; Fuller C; Drissi R; Jones BV; Leach J; Fouladi M
    Neuro Oncol; 2022 Jan; 24(1):141-152. PubMed ID: 34114629
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. h3f3a-mutated giant cell tumour of bone without giant cells-clinical presentation, radiology and histology of three cases.
    Leinauer B; Wolf E; Werner M; Baumhoer D; Breining T; Luebke AM; Maas R; Schultheiß M; von Baer A; Sufi-Siavach A; Moritz C; Geißler S; Mellert K; Möller P; Barth TFE; Jundt G
    Histopathology; 2021 Nov; 79(5):720-730. PubMed ID: 33991114
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. h3f3a G34 mutation DNA sequencing and G34W immunohistochemistry analysis in 366 cases of giant cell tumors of bone and other bone tumors.
    Gong L; Bui MM; Zhang W; Sun X; Zhang M; Yi D
    Histol Histopathol; 2021 Jan; 36(1):61-68. PubMed ID: 33021329
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma.
    Papke DJ; Hung YP; Schaefer IM; Bredella MA; Charville GW; Reith JD; Fletcher CDM; Nielsen GP; Hornick JL
    Mod Pathol; 2020 Nov; 33(11):2295-2306. PubMed ID: 32601382
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.